Incidence and impact of food aversions among patients with cancer receiving outpatient chemotherapy: a one-year prospective survey
Supportive Care in Cancer · 2024
DOI: 10.1007/s00520-024-09028-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Machi Suka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Environmental Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8461, …. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Outpatients. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Purpose
To determine the current incidence and impact of chemotherapy-associated food aversions in a variety of cancer types.
Methods
Cancer patients aged 18 years and older who received chemotherapy infusions at the outpatient chemotherapy unit of a university hospital between May 2022 and April 2023 were included in the study ( n = 243). To monitor the occurrence of food aversions, participants were asked to complete a food preference questionnaire each time they visited the outpatient chemotherapy unit.
Results
During the one-year survey period, one in four cancer patients receiving outpatient chemotherapy developed food aversions, and one in four of them complained of interference with daily life due to eating problems at the same time or later. The median time to the onset of food aversion was 46 (interquartile range 36–77) days after the start of chemotherapy. The incidence of food aversions was significantly higher in patients who were women, had a digestive, gynecologic, or breast cancer, and received more cytotoxic agents in chemotherapy. Patients who developed food aversions tended to lose more body weight than those who did not.
Conclusion
Food aversions were still common among cancer patients undergoing chemotherapy. Even an aversion to a single food may have affected the patient’s nutritional status. Healthcare professionals should closely monitor the occurrence of food aversions, especially in the early days of chemotherapy induction, to detect an increasing risk of malnutrition.
Trial registration
Not applicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Environmental Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8461, Japan. suka@jikei.ac.jp.
- Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
- The Jikei University Hospital, Tokyo, Japan.
- Department of Public Health and Environmental Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8461, Japan.
- The Jikei University School of Medicine, Tokyo, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Suka, M., Katsube, A., Fujimoto, R., Uwagawa, T., Shimada, T., Yano, S., Yamauchi, T., & Yanagisawa, H. (2024). Incidence and impact of food aversions among patients with cancer receiving outpatient chemotherapy: a one-year prospective survey. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-09028-7
Vancouver
Suka M, Katsube A, Fujimoto R, Uwagawa T, Shimada T, Yano S, et al. Incidence and impact of food aversions among patients with cancer receiving outpatient chemotherapy: a one-year prospective survey. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-09028-7
BibTeX
@article{Suka2024,
author = {Suka, Machi and Katsube, Atsushi and Fujimoto, Reiko and Uwagawa, Tadashi and Shimada, Takashi and Yano, Shingo and Yamauchi, Takashi and Yanagisawa, Hiroyuki},
title = {Incidence and impact of food aversions among patients with cancer receiving outpatient chemotherapy: a one-year prospective survey},
journal = {Supportive Care in Cancer},
year = {2024},
doi = {10.1007/s00520-024-09028-7}
}
EUVIMED